Skip to content

Company information lookup

PRANA BIOTECHNOLOGY LIMITED (PBT)

The Company's business is the development of therapeutic drugs for age-related diseases.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
PBT 0.240 -4% 0.240 0.255 0.260 0.260 0.240 1,067,988

PRANA BIOTECHNOLOGY LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code PBT
Securities
Official Listing Date 28 March, 2000
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.pranabio.com
Registered Office Address Suite 2, 1233 High Street, ARMADALE, VIC, AUSTRALIA, 3143
Head Office Telephone (03) 8692 9048
Head Office Fax (03) 8692 9040
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Geoffrey Kempler (Executive Chairman)
Mr Peter Marks (Director)
Prof. Ira Shoulson (Director)
Mr Lawrence Gozlan (Non Exec. Director)
Mr Brian Meltzer (Non Exec. Director)
Dr George Mihaly (Non Exec. Director)
Ms Dianne Angus (Chief Op. Officer)
Mr Richard Revelins (CFO)
Company Secretary Mr Richard Revelins
Principal Activities The Company's business is the development of therapeutic drugs for age-related diseases.

PRANA BIOTECHNOLOGY LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
05/09/2014 asterix FDA Orphan Drug Designation for PBT2 for Huntington Disease 2 PDF
05/09/2014 asterix Trading Halt 2 PDF
29/08/2014 asterix Appendix 4E & Preliminary Final Report 27 PDF
07/08/2014   Appendix 3B and 708A notice 12 PDF
31/07/2014 asterix Appendix 4C - quarterly 5 PDF
25/07/2014   Form F-3 3 PDF
17/07/2014 asterix Prana Alzheimers disease Development Program update 34 PDF
28/05/2014 asterix Response to ASX Price Query 4 PDF
16/05/2014   Initial Director's Interest Notice - IS 2 PDF
14/05/2014   Interview - Professor Ira Shoulson joins Prana Board 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
19 Sep 2014 0.240 -4% 0.260 0.240 1,067,988
18 Sep 2014 0.250 0% 0.255 0.250 113,098
17 Sep 2014 0.250 -5.66% 0.265 0.250 382,676
16 Sep 2014 0.265 1.15% 0.265 0.255 150,236
15 Sep 2014 0.262 0.77% 0.270 0.260 444,179

* Volume of shares shown represents only those shares traded on ASX.

PRANA BIOTECHNOLOGY LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security PBT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security PBT

Warrants & Structured Products

No warrants & Structured Products are available over the security PBT

ASX CFDs

No Contracts For Differences are available over the security PBT